Attendance

May 10, 2022

RCR urges action on future cancer workforce

October 24, 2025

Radiation Symbol Circle 400 (1)

RHYTHM Project launches for radiation safety education

October 24, 2025

Join Us!

October 22, 2025

Global Pharmaceutical Trade Network Adobe Tida

What’s the likely impact of €16B Hologic deal?

October 23, 2025

RCR urges action on future cancer workforce

By AuntMinnieEurope.com staff writers

The U.K. Royal College of Radiologists (RCR) has called for urgent action to bolster the future cancer workforce.

October 24, 2025

RHYTHM Project launches for radiation safety education

By AuntMinnieEurope.com staff writers

The RHYTHM Project, which includes the ESR, aims to improve medical imaging education and safety for young patients.

October 24, 2025

Radiation Symbol Circle 400 (1)

RCR updates guidance on breast imaging

By AuntMinnieEurope.com staff writers

The U.K. Royal College of Radiologists (RCR) has released a document offering free guidance to radiologists on screening and symptomatic breast imaging.

October 23, 2025

What’s the likely impact of €16B Hologic deal?

By Erik L. Ridley and Philip Ward

Private equity firms are acquiring women’s health vendor Hologic. Senior industry experts reflect on the deal and the future consequences for the global women’s health sector.

October 23, 2025

Global Pharmaceutical Trade Network Adobe Tida

PET/MRI begins to deliver in breast cancer

The clinical role of PET/MRI is evolving rapidly in breast cancer, according to two studies presented at the European Society of Breast Imaging annual meeting.

October 23, 2025

Dedicated breast F-18 FDG PET/MRI exam pre- (A, D, G), mid- (B, E, H), and post-NAC (C, F, I) of a 41-year-old patient diagnosed with a triple negative (TN), grade 2, invasive carcinoma. The SUVmax values of the primary tumor were 14.68 pre-NAC, 1.69 mid-NAC, and 1.87 post-NAC, while SER values were 1.19, 0.52, and 0.63, respectively. Figure courtesy of Melissa Lenaerts, PhD, Dr. Thiemo van Nijnatten, PhD, et al and presented at EUSOBI 2025.

EUSOBI: Positron emission mammography demonstrates worth

By Edna Astbury-Ward, PhD

Positron emission mammography is proving useful in the presurgical assessment of invasive lobular carcinoma, researchers reported at the European Society of Breast Imaging (EUSOBI) annual meeting.

October 22, 2025

A 399 Fig 2 Pem Vs Cesm E Poster Eusobi 2025 Deabes Thumbnail

Amyloid PET can track patterns of neurodegeneration

By Maryam Payne

Early perfusion amyloid-PET shows potential for diagnosing and monitoring neurodegenerative disease and has possible advantages over FDG-PET scanning.

October 22, 2025

2025 10 20 Eanm Early Perfusion Imaging Fig1 Thumbnail

Pluvicto reduces progression of advanced prostate cancer

By AuntMinnieEurope.com staff writers

New study findings were presented on 19 October at the European Society for Medical Oncology 2025 annual meeting in Berlin.

October 21, 2025

Prostate 3 D 400

The epidemic of decision paralysis

By Dr. Paul McCoubrie

Decision-making is central to successful clinical practice, but no one seems to make decisions these days, writes Dr. Paul McCoubrie in the second part of his series about interactions between surgeons and radiologists.

October 21, 2025

Paul Mc Coubrie April 24

Global survey pinpoints key trends in spectral CT

The use of spectral CT is rising, but its clinical integration and quality assurance/quality control practices are inconsistent, the International Atomic Energy Agency has found.

October 20, 2025

Ct Scan Tech Adobe Stock By Peakstock g3ma9suare

Abnormal CT-FFR results translate to up to 7 years' cardiac risk

By Kate Madden Yee

The prognostic value of CT fractional flow reserve (CT-FFR) has been unclear, but the findings of a recent study from Denmark offer further insight.

October 20, 2025

Transgender breast care emerges as priority for radiology

By Frances Rylands-Monk

Radiology needs to stop thinking of breast cancer as a disease that only concerns women and do much more to include transgender patients in breast care, says Dr. Anna D'Angelo from Rome.

October 20, 2025

Page 1 of 1296